Infusil India Private Limited, a active private limited company, was established on 27 January 1992 in Bangalore, Karnataka, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U29224KA1992PTC012757. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.27 M.
Formerly known as Bhanu Scientific Instruments Company Pvt Ltd. It upholds a compliant status. Employing 13 professional, Its leadership includes Swamy Ravi (Director), Chitgopeker Bhanu Manoj (Director), Bhanu Swamy (Director). Past directors included Hampapura Narasimhamurthy Ravi, Surya Ravi, Swamy Ravi. It holds ₹1.05 Cr open charges and ₹1.47 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Infusil House, Plot No.174, 11Th Main, 3Rd Phase, Peenya Industrial Area,, Bangalore, Karnataka, 560058.
U29224KA1992PTC012757
012757
27 January 1992
₹2.50 M
₹0.27 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Infusil India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swamy Ravi | Director | 16 Apr 2009 | Current |
| Chitgopeker Bhanu Manoj | Director | 15 Oct 1992 | Current |
| Bhanu Swamy | Director | 14 Feb 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Jul 2013 | Past |
| Pramod Abcsdd | Director | 01 Aug 2007 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Infusil India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.65% increase. The company also saw a substantial improvement in profitability, with a 279.1% increase in profit. The company's net worth moved up by a moderate rise of 2.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Infusil India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,450,000.00
₹14,650,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2022 | State Bank Of India | ₹1.05 Cr | Open |
| 09 Sep 2010 | State Bank Of Mysore | ₹9.65 M | Satisfied |
| 16 Aug 2006 | State Bank Of Mysore | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Infusil India has a workforce of 13 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Infusil India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infusil India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Infusil India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Infusil India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
A charge registered on 09 Sep 2010 via Charge ID 10252408 with State Bank Of Mysore was fully satisfied on 24 Nov 2022. was recorded as a recent event.
Progress on A charge registered on 16 Aug 2006 via Charge ID 10017619 with State Bank Of Mysore was fully satisfied on 24 Nov 2022. was documented.
A charge with State Bank Of India amounted to Rs. 10.45 M with Charge ID 100644767 was registered on 07 Nov 2022. was recorded as a recent event.
Progress on A charge with State Bank Of Mysore of Rs. 9.65 M registered on 09 Sep 2010 with Charge ID 10252408 was modified on 08 May 2014. was documented.
The CIN of Infusil India Private Limited is U29224KA1992PTC012757.
Infusil India Private Limited is headquartered at Infusil House, Plot No.174, 11Th Main, 3Rd Phase, Peenya Industrial Area,, Bangalore, Karnataka, 560058.
Infusil India Private Limited was incorporated on 27 January 1992.
The current directors of Infusil India Private Limited are
The primary industry of Infusil India Private Limited is Manufacturing.
Infusil India Private Limited is unlisted.
The authorized capital of Infusil India Private Limited is ₹2.50 M, and the paid-up capital is ₹0.27 M.
The compliance status of Infusil India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX